引用本文:王尤洪.他汀类药物治疗2型糖尿病患者高脂血症的成本-效果分析[J].中国临床新医学,2009,2(8):811-814.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 944次   下载 809 本文二维码信息
码上扫一扫!
分享到: 微信 更多
他汀类药物治疗2型糖尿病患者高脂血症的成本-效果分析
王尤洪
528414 广东,中山市东升医院
摘要:
[摘要] 目的 研究他汀类药物在治疗2型糖尿病患者高脂血症的疗效和成本,找出一种费用较低、效果显著的治疗方案。方法 将收治的168例2型糖尿病高脂血症患者随机分为为A(氟伐他汀)、B(洛伐他汀)、C(普伐他汀)、D(辛伐他汀)4组,比较各组疗效,并进行成本-效果分析。结果 A、B、C、D组疗效分别为85.71%、88.10%、83.33%、90.48%(P>0.05),成本-效果比分别为166.58、95.77、163.16、84.90。结论 辛伐他汀具有最低的单位效果成本,值得临床上应用。
关键词:  2型糖尿病  高脂血症  他汀类药物  成本-效果分析
DOI:10.3969/j.issn.1674-3806.2009.08.13
分类号:R 587.1
基金项目:
Cost-effectiveness analysis on statins in the treatment of type 2 diabetes patients with hyperlipoidemia
WANG You-hong
Dongsheng Hospital, Zhongshan Guangdong 528414, China
Abstract:
[Abstract] Objective To analysies the cost-effectiveness on statins in the treatment of type 2 diabetes patients with hyperlipoidemia and find out a low-cost and effective treatment scheme. Methods One hundred and sixty-eight type 2 diabetes patients with hyperlipoidemia were randomly divided into 4 groups, Group A received fluvastatin, Group B received lovastatin, Group C received provastatin and Group D received simvastatin. The therapeutic effects and cost-effectiveness were compared in 4 groups.Results The effective rates of Groups A, B, C and D were 85.71%、88.10%、83.33%、90.48%, respectively(P>0.05), the cost-effectiveness ratios were 166.58、95.77、163.16、84.90 respectively.Conclusion Simvastatin is the optimal treatment for type 2 diabetes patients with hyperlipoidemia.
Key words:  Type 2 diabetes  Hyperlipoidemia  Statins  Cost-effectiveness analysis